Table of Contents
Cost-effectiveness of converting non-sedating antihistamines from prescription to over-the-counter status
Study Purpose
Cost-effectiveness Models
Cost-Effectiveness Model Structure
PPT Slide
PPT Slide
Key Base Case Assumptions
Key Base Case Assumptions
Base Case Results
ICER Sensitivity Analysis: Percent Drop in Non-sedating Price After OTC Conversion
ICER Sensitivity Analysis: Percent of Patients Treated by MD
ICER Sensitivity Analysis: Non-sedating Market Share, Given MD Visit
ICER Sensitivity Analysis: Effect of Rate of Sedation from Sedating Antihistamines
Study Assumptions
Future Analyses
Conclusions
|
Author: Michael B. Nichol
|